Jette Steinbach

Jette Steinbach

Auto-generated profile, based on publicly available information

Jette Steinbach

National Centre for Register-based Research, Aarhus University, Denmark

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
EPEmil M. Pedersen
Emil M. Pedersen
EAEsben Agerbo
Esben Agerbo
OPOleguer Plana-Ripoll
Oleguer Plana-Ripoll
JSJette Steinbach
Jette Steinbach
MKMorten D. Krebs
Morten D. Krebs
BVBjarni J. Vilhjálmsson
Bjarni J. Vilhjálmsson
Proportional hazards models have been proposed to analyse time-to-event phenotypes in genome-wide association studies (GWAS). However, little is known about the ability of proportional hazards models to identify genetic associations under different generative models and when ascertainment is present. Here we propose the age-dependent liability threshold (ADuLT) model as an alternative to a Cox regression based GWAS, here represented by SPACox. We compare ADuLT, SPACox, and standard case-control GWAS in simulations under two generative models and with varying degrees of ascertainment as well as in the iPSYCH cohort. We find Cox regression GWAS to be underpowered when cases are strongly ascertained (cases are oversampled by a factor 5), regardless of the generative model used. ADuLT is robust to ascertainment in all simulated scenarios. Then, we analyse four psychiatric disorders in iPSYCH, ADHD, Autism, Depression, and Schizophrenia, with a strong case-ascertainment. Across these psychiatric disorders, ADuLT identifies 20 independent genome-wide significant associations, case-control GWAS finds 17, and SPACox finds 8, which is consistent with simulation results. As more genetic data are being linked to electronic health records, robust GWAS methods that can make use of age-of-onset information will help increase power in analyses for common health outcomes.

14 October 2024 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
JMJessica Mundy
Jessica Mundy
AHAlisha S. M. Hall
Alisha S. M. Hall
JSJette Steinbach
Jette Steinbach
CAClara Albinaña
Clara Albinaña
EAEsben Agerbo
Esben Agerbo
KMKatherine L. Musliner
Katherine L. Musliner
Background: The clinical course of major depressive disorder (MDD) is heterogeneous, and early-onset MDD often has a more severe and complex clinical course. Our goal was to determine whether polygenic scores (PGSs) for psychiatric disorders are associated with treatment trajectories in early-onset MDD treated in secondary care.Methods: Data were drawn from the iPSYCH2015 sample, which includes all individuals born in Denmark between 1981 and 2008 who were treated in secondary care for depression between 1995 and 2015. We selected unrelated individuals of European ancestry with an MDD diagnosis between ages 10–25 (N = 10577). Seven-year trajectories of hospital contacts for depression were modeled using Latent Class Growth Analysis. Associations between PGS for MDD, bipolar disorder, schizophrenia, ADHD, and anorexia and trajectories of MDD contacts were modeled using multinomial logistic regressions.Results: We identified four trajectory patterns: brief contact (65%), prolonged initial contact (20%), later re-entry (8%), and persistent contact (7%). Relative to the brief contact trajectory, higher PGS for ADHD was associated with a decreased odds of membership in the prolonged initial contact (odds ratio = 1.06, 95% confidence interval = 1.01–1.11) and persistent contact (1.12, 1.03–1.21) trajectories, while PGS-AN was associated with increased odds of membership in the persistent contact trajectory (1.12, 1.03–1.21).Conclusions: We found significant associations between polygenic liabilities for psychiatric disorders and treatment trajectories in patients with secondary-treated early-onset MDD. These findings help elucidate the relationship between a patient's genetics and their clinical course; however, the effect sizes are small and therefore unlikely to have predictive value in clinical settings.

2 January 2025 in Acta Psychiatrica Scandinavica
Verified
Journal Article
Open access
JMJessica Mundy
Jessica Mundy
AHAlisha S. M. Hall
Alisha S. M. Hall
EAEsben Agerbo
Esben Agerbo
CAClara Albiñana
Clara Albiñana
JSJette Steinbach
Jette Steinbach
KMKatherine L. Musliner
Katherine L. Musliner
Background: Previous research has shown that females who use hormonal contraception are at increased risk of developing depression, and that the risk is highest among adolescents. While this finding could reflect age‐specific effects of exogenous hormones on mental health, genetic liability for mental disorders could be confounding the association. Our goal was to test the plausibility of this hypothesis by determining whether polygenic liabilities for major depressive disorder (MDD), bipolar disorder (BD), schizophrenia (SCZ), and attention deficit hyperactivity disorder (ADHD) are associated with younger age at hormonal contraception initiation.Methods: We conducted a cohort study using data from the Danish iPSYCH2015 sub‐cohort, a representative sample of people born in Denmark between May 1981 and December 2008. Polygenic scores (PGSs) for MDD, BD, SCZ, and ADHD were created using the most recent genome‐wide association study meta‐analyses from the Psychiatric Genomics Consortium. Associations between PGSs and hormonal contraception initiation in the following age categories: 10–14, 15–19, 20–24, and 25+ were examined via Cox regression. We examined any hormonal contraception, oral contraception, and non‐oral contraception.Results: PGS‐MDD and PGS‐ADHD showed the strongest associations with hormonal contraception initiation at age 10–14 (PGS‐ADHD: HR = 1.21 [95% CI = 1.16–1.27], p = 6.16 x 10−18; PGS‐MDD: 1.21 [1.16–1.27], p = 1.22 x 10−17). The associations then steadily decreased as age at hormonal contraception initiation increased. Both PGS‐MDD and PGS‐ADHD were also associated with initiation at ages 15–19, but not at 20–24 or 25+. PGS‐BD and PGS‐SCZ were also associated, albeit not as strongly, with initiation at age 10–14 only (PGS‐BD: 1.07 [1.02–1.13], p = 6.87 × 10−3; PGS‐SCZ: 1.09 [1.04–1.14], p = 8.61 × 10−4).Conclusions and Relevance: These results suggest that genetic confounding could explain some of the association between early hormonal contraception use and depression. Where possible, researchers studying this important topic should account for possible confounding by genetic liability for mental disorders.

8 October 2025 in medRxiv
Verified
Preprint
Open access
PDF file
TGTahereh Gholipourshahraki
Tahereh Gholipourshahraki
LELinda Ejlskov
Linda Ejlskov
BSBirgitte Dige Semark
Birgitte Dige Semark
GMGenona Torruella Maseras
Genona Torruella Maseras
JSJette Steinbach
Jette Steinbach
BVBjarni Jóhann Vilhjálmsson
Bjarni Jóhann Vilhjálmsson
Background Psychiatric disorders represent a significant global health burden with complex etiologies involving both genetic and environmental factors. However, while the main effects of genetic and environmental factors are frequently studied, their interplay in shaping psychiatric disorder risk remains poorly understood. This study investigates the interaction between polygenic scores (PGS) as proxies for genetic risk and environmental factors in the risk of psychiatric disorders. Method This study utilized the iPSYCH case-cohort sample (n = 141,265). Environmental factors, including region, urbanicity, parental socioeconomic status, parental age, parental psychiatric history and early-life exposures: autoimmune disease, brain injury, and central nervous system (CNS) infections, were obtained from Danish nationwide registers. Logistic regression was used to examine the effects of targeted disorder-specific PGSs, environmental factors and their interactions on psychiatric disorders. Analyses were adjusted for age, sex and ancestral principal components to account for population stratification. Results Both PGS and environmental factors were associated with psychiatric disorders. We found limited evidence of gene–environment interactions across the investigated psychiatric disorders. Most interaction terms were small and not statistically significant, but a few remained significant. These included a smaller PGS association with attention deficit hyperactivity disorder in Southern Denmark compared with the Capital Region, a reduced PGS association with bipolar disorder in the medium and lowest parental income groups compared with the highest income group, and a weaker PGS association with major depressive disorder in individuals with parental psychiatric history compared with those without such history. In contrast, a larger PGS association with schizophrenia was observed in the paternal age group 31–35 years compared with the 26–30 years reference group, and a stronger PGS association with anorexia nervosa in North Denmark compared with the Capital Region. Conclusion Genetic liability for psychiatric disorders, captured through PGS, was associated with mental disorder risk across environmental contexts. Only a few gene–environment interactions were significant, and these were modest and mental disorder-specific. Overall, the findings highlight the difficulty of detecting robust gene–environment interactions and the need for studies of sufficient scale and statistical power to identify subtle gene–environment effects and improve understanding of psychiatric disorder etiology.

16 May 2025 in medRxiv
Verified
Preprint
Open access
PDF file
EPEmil Michael Pedersen
Emil Michael Pedersen
JSJette Steinbach
Jette Steinbach
CPCarsten B. Pedersen
Carsten B. Pedersen
ASAndrew Schork
Andrew Schork
MKMorten Dybdahl Krebs
Morten Dybdahl Krebs
FPFlorian Privé
Florian Privé
Summary: Research in the familial aggregation of diseases and traits utilise information on probands, and their relevant health information enriched with similar information for their family members of interest. The genealogy is typically generated from trio information in registers and biobanks. However it can be tedious and error prone to identify family members other than first-degree relatives. Here, we present a graph-based approach to effectively identify family members of arbitrary degree of relatedness, as well as the means to attach any desired information to each individual for downstream analysis and a function to efficiently calculate a kinship matrix for the identified family members and convert identified family members from a graph back into trio information. Availability and Implementation: The R package where these new functionalities are implemented is available on GitHub ( https://github.com/EmilMiP/LTFHPlus ) and on CRAN ( https://cran.r-project.org/web/packages/LTFHPlus/index.html ).

19 June 2026 in bioRxiv
Verified
Preprint
Open access
EPEmil M. Pedersen
Emil M. Pedersen
JSJette Steinbach
Jette Steinbach
MVMathias Valstad
Mathias Valstad
HOHenrik Ohlsson
Henrik Ohlsson
LRLucas A. Rasmussen
Lucas A. Rasmussen
MKMorten D. Krebs
Morten D. Krebs
Estimates of per-individual genetic liability from large-scale family data are routinely used in biomedical research to describe genetic etiology of traits and disorders, boost the power of gene-mapping studies, and improve risk predictions. Here we present LT-FGRS, an R package for handling population-scale pedigrees and implementing multiple state-of-the-field methods for estimating genetic liability from such data. Benchmarking in population-scale Nordic registry data demonstrates that LT-FGRS reproduces estimates from existing implementations at manageable computational cost. LT-FGRS unifies previous parallel implementations into a single framework, lowering barriers for methodological comparison and applied use. Availability and Implementation: LT-FGRS is available as an R-package on CRAN. ( https://CRAN.R-project.org/package=LTFGRS ) Contact: emp@au.dk ; morten.dybdahl.krebs@regionh.dk Supplementary information: https://emilmip.github.io/LTFGRS